Protein-driven nanomedicines in oncotherapy.

Area of Science:

• Biochemistry
• Nanotechnology
• Oncology

Background:

• Proteins are vital organic macromolecules with diverse applications in medicine and industry, particularly as therapeutic agents.
• In oncology, proteins are engineered into nanocarriers for targeted drug delivery to tumors.
• Achieving nanoscale size often involves the oligomeric assembly of protein components.

Purpose of the Study:

• To explore the engineering of highly cytotoxic proteins into self-assembling nanostructures for cancer therapy.
• To develop virus-like, nanometric protein constructs for targeting metastatic cancer stem cells.
• To investigate the potential of these constructs for direct metastasis destruction without auxiliary delivery systems.

Main Methods:

• Engineering of highly cytotoxic proteins (e.g., microbial or plant toxins).
• Design of self-assembling protein constructs to form virus-like, nanometric structures.
• Evaluation of targeting capabilities towards metastatic cancer stem cells.

Main Results:

• Successfully engineered cytotoxic proteins into homogeneous, nanometric, virus-like structures.
• Demonstrated the ability of these protein nanostructures to target metastatic cancer stem cells.
• Showcased the potential for direct destruction of metastasis via self-delivered protein nanoparticles.

Conclusions:

• Engineered cytotoxic proteins can self-assemble into effective nanomedicines for cancer therapy.
• These virus-like protein nanoparticles offer a novel strategy for targeting and eliminating metastatic cancer stem cells.
• This approach bypasses the need for separate drug carriers, simplifying targeted delivery.